BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hickman L, Contreras C. Gallbladder Cancer: Diagnosis, Surgical Management, and Adjuvant Therapies. Surg Clin North Am. 2019;99:337-355. [PMID: 30846038 DOI: 10.1016/j.suc.2018.12.008] [Cited by in Crossref: 38] [Cited by in F6Publishing: 25] [Article Influence: 12.7] [Reference Citation Analysis]
Number Citing Articles
1 Li J, Zhang H, Luo H. Long Non-Coding RNA OIP5-AS1 Contributes to Gallbladder Cancer Cell Invasion and Migration by miR-143-3p Suppression. Cancer Manag Res 2020;12:12983-92. [PMID: 33364844 DOI: 10.2147/CMAR.S278719] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Singh L, M. K, Rija M, Manoharan R. Management of a Suspected Case of Gallbladder Cancer with Individualised Homoeopathy: A Case Report. Homœopathic Links 2021;34:300-6. [DOI: 10.1055/s-0041-1740239] [Reference Citation Analysis]
3 Kim TH, Woo SM, Lee WJ, Oh ES, Youn SH, Moon SH, Kim SS, Han SS, Park SJ, Kim DY. Benefit of Adjuvant Chemoradiotherapy in Resected Gallbladder Carcinoma. Sci Rep 2019;9:11770. [PMID: 31409811 DOI: 10.1038/s41598-019-48099-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
4 Prieto-ortiz RG, Borráez-segura BA, Prieto-ortiz JE, Guevara-cruz ÓA. Cáncer de vesícula biliar, una visión actual. Rev Colomb Cir 2022. [DOI: 10.30944/20117582.891] [Reference Citation Analysis]
5 Kellil T, Chaouch MA, Aloui E, Tormane MA, Taieb SK, Noomen F, Zouari K. Incidence and Preoperative Predictor Factors of Gallbladder Cancer Before Laparoscopic Cholecystectomy: a Systematic Review. J Gastrointest Cancer 2021;52:68-72. [PMID: 32964323 DOI: 10.1007/s12029-020-00524-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 John S, Moyana T, Shabana W, Walsh C, McInnes MDF. Gallbladder Cancer: Imaging Appearance and Pitfalls in Diagnosis [Formula: see text]. Can Assoc Radiol J 2020;71:448-58. [PMID: 32412302 DOI: 10.1177/0846537120923273] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Ramachandran A, Srivastava DN, Madhusudhan KS. Gallbladder cancer revisited: the evolving role of a radiologist. Br J Radiol 2021;94:20200726. [PMID: 33090880 DOI: 10.1259/bjr.20200726] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Klimkowski SP, Fung A, Menias CO, Elsayes KM. Gallbladder Imaging Interpretation Pearls and Pitfalls. Radiologic Clinics of North America 2022. [DOI: 10.1016/j.rcl.2022.05.002] [Reference Citation Analysis]
9 Wang CC, Tsai MC, Wang SC, Peng CM, Lee HL, Chen HY, Yang TW, Lin CC, Sung WW. Favorable gallbladder cancer mortality-to-incidence ratios of countries with good ranking of world's health system and high expenditures on health. BMC Public Health 2019;19:1025. [PMID: 31366338 DOI: 10.1186/s12889-019-7160-z] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
10 Nugent JP, Li J, Pang E, Harris A. What's new in the hot gallbladder: the evolving radiologic diagnosis and management of acute cholecystitis. Abdom Radiol (NY) 2022. [PMID: 35230497 DOI: 10.1007/s00261-022-03451-2] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Dixit R, Pandey M, Rajput M, Shukla VK. Unravelling of the comparative Transcriptomic Profile of Gallbladder Cancer using mRNA sequencing. Mol Biol Rep 2022. [PMID: 35469389 DOI: 10.1007/s11033-022-07448-4] [Reference Citation Analysis]
12 Lopes Vendrami C, Magnetta MJ, Mittal PK, Moreno CC, Miller FH. Gallbladder Carcinoma and Its Differential Diagnosis at MRI: What Radiologists Should Know. Radiographics 2021;41:78-95. [PMID: 33306452 DOI: 10.1148/rg.2021200087] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Liu K, Lin N, You Y, Zhao D, Wu J, Wang S, Lu Y. Risk factors to discriminate neoplastic polypoid lesions of gallbladder: A large scale, case-series study. Asian J Surg 2021:S1015-9584(21)00107-X. [PMID: 33771426 DOI: 10.1016/j.asjsur.2021.03.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Bains L, Maranna H, Lal P, Kori R, Kaur D, Mallya V, Singh V. The giant resectable carcinoma of gall bladder-a case report. BMC Surg 2021;21:133. [PMID: 33726732 DOI: 10.1186/s12893-021-01117-2] [Reference Citation Analysis]
15 Zhang B, Li S, Liu ZY, Peiris KGK, Song LF, Liu MC, Luo P, Shang D, Bi W. Successful multimodality treatment of metastatic gallbladder cancer: A case report and review of literature. World J Clin Cases 2022; 10(12): 3856-3865 [DOI: 10.12998/wjcc.v10.i12.3856] [Reference Citation Analysis]
16 Wang L, Wang J, Gong K, Shen Q, Fu H, Huang H, Chen C, Zhang L, Duan Y, Suo T. Amyloid Precursor Protein Influences Gallbladder Cancer Cell Behaviors and may be an Effective Prognostic Factor. Nano LIFE 2020;10:2040002. [DOI: 10.1142/s1793984420400024] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Lin Z, Yang S, Zhou Y, Hou Z, Li L, Meng M, Ge C, Zeng B, Lai J, Gao H, Zhao Y, Xie Y, He S, Tang W, Li R, Tan J, Wang W. OLFM4 depletion sensitizes gallbladder cancer cells to cisplatin through the ARL6IP1/caspase-3 axis. Transl Oncol 2022;16:101331. [PMID: 34974280 DOI: 10.1016/j.tranon.2021.101331] [Reference Citation Analysis]
18 Koppatz H, Takala S, Peltola K, But A, Mäkisalo H, Nordin A, Sallinen V. Gallbladder cancer epidemiology, treatment and survival in Southern Finland - a population-based study. Scand J Gastroenterol 2021;56:929-39. [PMID: 34224306 DOI: 10.1080/00365521.2021.1915373] [Reference Citation Analysis]
19 Kuipers H, Hoogwater FJ, Holtman GA, van der Hoorn A, de Boer MT, de Haas RJ. Clinical value of diffusion-weighted MRI for differentiation between benign and malignant gallbladder disease: a systematic review and meta-analysis. Acta Radiol 2021;62:987-96. [PMID: 32830511 DOI: 10.1177/0284185120950115] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
20 Jia Y, Samadzadeh S, Cornford M, Ji P, French SW. Educational Case: Incidental Gallbladder Adenocarcinoma. Acad Pathol 2020;7:2374289520909504. [PMID: 32206701 DOI: 10.1177/2374289520909504] [Reference Citation Analysis]
21 Wu S, Zou X, Wang Q, Hu D, Li Z, Xu C. Gallbladder carcinoma: an initial clinical experience of reduced field-of-view diffusion-weighted MRI. Cancer Imaging 2020;20:50. [PMID: 32680571 DOI: 10.1186/s40644-020-00326-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
22 Li M, Fan K, Zheng B, Zekria D, Suo T, Liu H, Shen S, Liu H, Ni X. Knockdown of SLC39A4 Expression Inhibits the Proliferation and Motility of Gallbladder Cancer Cells and Tumor Formation in Nude Mice. Cancer Manag Res 2021;13:2235-46. [PMID: 33727860 DOI: 10.2147/CMAR.S282269] [Reference Citation Analysis]
23 Björk D, Bartholomä W, Hasselgren K, Edholm D, Björnsson B, Lundgren L. Malignancy in elective cholecystectomy due to gallbladder polyps or thickened gallbladder wall: a single-centre experience. Scand J Gastroenterol 2021;56:458-62. [PMID: 33590795 DOI: 10.1080/00365521.2021.1884895] [Reference Citation Analysis]
24 Yang Y, Tu Z, Ye C, Cai H, Yang S, Chen X, Tu J. Site-specific metastases of gallbladder adenocarcinoma and their prognostic value for survival: a SEER-based study. BMC Surg 2021;21:59. [PMID: 33485332 DOI: 10.1186/s12893-021-01068-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
25 Sharma N, Yadav M, Tripathi G, Mathew B, Bindal V, Falari S, Pamecha V, Maras JS. Bile multi-omics analysis classifies lipid species and microbial peptides predictive of carcinoma of gallbladder. Hepatology 2022. [PMID: 35357716 DOI: 10.1002/hep.32496] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Song X, Hu Y, Li Y, Shao R, Liu F, Liu Y. Overview of current targeted therapy in gallbladder cancer. Signal Transduct Target Ther 2020;5:230. [PMID: 33028805 DOI: 10.1038/s41392-020-00324-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
27 Frountzas M, Schizas D, Liatsou E, Economopoulos KP, Nikolaou C, Apostolou KG, Toutouzas KG, Felekouras E. Presentation and surgical management of xanthogranulomatous cholecystitis. Hepatobiliary Pancreat Dis Int 2021;20:117-27. [PMID: 33536138 DOI: 10.1016/j.hbpd.2021.01.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
28 Wang RT, Miao RC, Zhang X, Yang GH, Mu YP, Zhang ZY, Qu K, Liu C. Fork head box M1 regulates vascular endothelial growth factor-A expression to promote the angiogenesis and tumor cell growth of gallbladder cancer. World J Gastroenterol 2021; 27(8): 692-707 [PMID: 33716448 DOI: 10.3748/wjg.v27.i8.692] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
29 Sui Z, Sui X. Long non-coding RNA TMPO-AS1 promotes cell proliferation, migration, invasion and epithelial-to-mesenchymal transition in gallbladder carcinoma by regulating the microRNA-1179/E2F2 axis. Oncol Lett 2021;22:855. [PMID: 34777589 DOI: 10.3892/ol.2021.13116] [Reference Citation Analysis]
30 Yang ML, Dai SL. Advances in research of molecular genetics of gallbladder cancer. Shijie Huaren Xiaohua Zazhi 2019; 27(14): 903-906 [DOI: 10.11569/wcjd.v27.i14.903] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
31 Ma W, Li W, Wang J, Wu R, Liu C, Feng F, Jiang X. The Clinical Role of Preoperative Serum CA19-9 and Carcinoembryonic Antigen (CEA) Levels in Evaluating the Resectability of Advanced Gallbladder Cancer. Med Sci Monit 2020;26:e925017. [PMID: 32950997 DOI: 10.12659/MSM.925017] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
32 Riquelme I, Pérez-Moreno P, Letelier P, Brebi P, Roa JC. The Emerging Role of PIWI-Interacting RNAs (piRNAs) in Gastrointestinal Cancers: An Updated Perspective. Cancers (Basel) 2021;14:202. [PMID: 35008366 DOI: 10.3390/cancers14010202] [Reference Citation Analysis]
33 Wang S, Su TT, Tong H, Shi W, Ma F, Quan Z. CircPVT1 promotes gallbladder cancer growth by sponging miR-339-3p and regulates MCL-1 expression. Cell Death Discov 2021;7:191. [PMID: 34312371 DOI: 10.1038/s41420-021-00577-y] [Reference Citation Analysis]
34 Wagner D, Werkgartner G, Kaczirek K. Management of early-stage gallbladder cancer. Eur Surg 2021;53:124-7. [DOI: 10.1007/s10353-021-00718-8] [Reference Citation Analysis]
35 Jefferys D, Roy S, Majid A. Incidental adenocarcinoma of the gallbladder in a patient with Y insertion gallbladder duplication in the context of recurrent biliary colic: A video case report. Medicine (Baltimore) 2022;101:e28829. [PMID: 35212280 DOI: 10.1097/MD.0000000000028829] [Reference Citation Analysis]
36 Huang LF, Hong A, Cioffi G, Alahmadi A, Tang TY, Ocuin LM, Patil N, Bajor DL, Saltzman JN, Mohamed A, Selfridge E, Webb Hooper M, Barnholtz-Sloan J, Lee RT. Associations of Racial and Ethnic Category, Age, Comorbidities, and Socioeconomic Factors on Concordance to NCCN Guidelines for Patients With High-Risk Biliary Tract Cancers After Surgery. Front Oncol 2022;12:771688. [PMID: 35273909 DOI: 10.3389/fonc.2022.771688] [Reference Citation Analysis]
37 Goel S, Aggarwal A, Iqbal A, Talwar V, Mitra S, Singh S. Multimodality management of gallbladder cancer can lead to a better outcome: Experience from a tertiary care oncology centre in North India. World J Gastroenterol 2021; 27(45): 7813-7830 [PMID: 34963744 DOI: 10.3748/wjg.v27.i45.7813] [Reference Citation Analysis]
38 Kumar P, Yadav M, Verma K, Dixit R, Singh J, Tiwary SK, Narayan G, Dixit VK. Expression analysis of aryl hydrocarbon receptor repressor (AHRR) gene in gallbladder cancer. Saudi J Gastroenterol 2021;27:54-9. [PMID: 32801256 DOI: 10.4103/sjg.SJG_213_20] [Reference Citation Analysis]
39 Fu C, Nie L, Yin T, Xu X, Lu W. LncRNA EPIC1 promotes proliferation and inhibits apoptosis of gallbladder cancer cells by interacting with LET. Ann Hepatol 2021;:100563. [PMID: 34653690 DOI: 10.1016/j.aohep.2021.100563] [Reference Citation Analysis]
40 Lyu WJ, Shu YJ, Liu YB, Dong P. Topoisomerase II alpha promotes gallbladder cancer proliferation and metastasis through activating phosphatidylinositol 3-kinase/protein kinase B/mammalian target of rapamycin signaling pathway. Chin Med J (Engl) 2020;133:2321-9. [PMID: 32925281 DOI: 10.1097/CM9.0000000000001075] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
41 Yang Y, Tu Z, Cai H, Hu B, Ye C, Tu J. A predictive nomogram for lymph node metastasis of incidental gallbladder cancer: a SEER population-based study. BMC Cancer 2020;20:828. [PMID: 32867722 DOI: 10.1186/s12885-020-07341-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
42 Cocco G, Delli Pizzi A, Basilico R, Fabiani S, Taraschi AL, Pascucci L, Boccatonda A, Catalano O, Schiavone C. Imaging of gallbladder metastasis. Insights Imaging 2021;12:100. [PMID: 34259932 DOI: 10.1186/s13244-021-01049-8] [Reference Citation Analysis]
43 Zhu D, Gu X, Lin Z, Yu D, Wang J. High expression of PSMC2 promotes gallbladder cancer through regulation of GNG4 and predicts poor prognosis. Oncogenesis 2021;10:43. [PMID: 34016944 DOI: 10.1038/s41389-021-00330-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 Tharmalingam S, Flemming J, Richardson H, Hurlbut D, Cleary S, Nanji S. Surgical practice patterns and outcomes in T2 and T3 gallbladder cancer: a population-based study. Can J Surg 2022;65:E16-24. [PMID: 35017185 DOI: 10.1503/cjs.019719] [Reference Citation Analysis]
45 Jiang TY, Feng XF, Fang Z, Cui XW, Lin YK, Pan YF, Yang C, Ding ZW, Zhang YJ, Tan YX, Wang HY, Dong LW. PTEN deficiency facilitates the therapeutic vulnerability to proteasome inhibitor bortezomib in gallbladder cancer. Cancer Lett 2021;501:187-99. [PMID: 33220333 DOI: 10.1016/j.canlet.2020.11.016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
46 Uzun MA, Tilki M, Gönültaş A, Aker F, Kayaoglu SA, Okuyan GÇ. Is the tumor-stroma ratio a prognostic factor in gallbladder cancer? Rev Assoc Med Bras 2022;68:664-9. [DOI: 10.1590/1806-9282.20220037] [Reference Citation Analysis]
47 Kirishima M, Yokoyama S, Matsuo K, Hamada T, Shimokawa M, Akahane T, Sugimoto T, Tsurumaru H, Ishibashi M, Mataki Y, Ootsuka T, Nomoto M, Hayashi C, Horiguchi A, Higashi M, Tanimoto A. Gallbladder microbiota composition is associated with pancreaticobiliary and gallbladder cancer prognosis. BMC Microbiol 2022;22:147. [PMID: 35624429 DOI: 10.1186/s12866-022-02557-3] [Reference Citation Analysis]
48 May M, Raufi AG, Sadeghi S, Chen K, Iuga A, Sun Y, Ahmed F, Bates S, Manji GA. Prolonged Response to HER2-Directed Therapy in Three Patients with HER2-Amplified Metastatic Carcinoma of the Biliary System: Case Study and Review of the Literature. Oncologist 2021;26:640-6. [PMID: 33896096 DOI: 10.1002/onco.13800] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]